TriSalus Life Sciences (TLSI) Misses Q3 EPS by 96c

TriSalus Life Sciences (NASDAQ: TLSI) reported Q3 EPS of ($0.96). Revenue for the quarter came in at $11.6 million.

For earnings history and earnings-related data on TriSalus Life Sciences (TLSI) click here.

You May Also Be Interested In

• Saudi Arabia Oil Pipeline Struck By Projectiles Thursday - CNN
• Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh
• Shoe Station Group (SHOE) PT Lowered to $15 at Williams Trading